Annual Cash & Cash Equivalents
$16.71 M
+$7.01 M+72.37%
December 31, 2024
Summary
- As of March 12, 2025, RXST annual cash & cash equivalents is $16.71 million, with the most recent change of +$7.01 million (+72.37%) on December 31, 2024.
- During the last 3 years, RXST annual cash & cash equivalents has fallen by -$7.66 million (-31.42%).
- RXST annual cash & cash equivalents is now -31.42% below its all-time high of $24.36 million, reached on December 31, 2021.
Performance
RXST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.71 M
-$14.00 K-0.08%
December 31, 2024
Summary
- As of March 12, 2025, RXST quarterly cash and cash equivalents is $16.71 million, with the most recent change of -$14.00 thousand (-0.08%) on December 31, 2024.
- Over the past year, RXST quarterly cash and cash equivalents has stayed the same.
- RXST quarterly cash and cash equivalents is now -75.53% below its all-time high of $68.28 million, reached on September 30, 2021.
Performance
RXST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RXST Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.4% | 0.0% |
| 3 y3 years | -31.4% | 0.0% |
| 5 y5 years | +109.9% | 0.0% |
RXST Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | +72.4% | -48.8% | +90.9% |
| 5 y | 5-year | -31.4% | +109.9% | -75.5% | +90.9% |
| alltime | all time | -31.4% | +109.9% | -75.5% | +90.9% |
RxSight Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $16.71 M(+72.4%) | $16.71 M(-0.1%) |
| Sep 2024 | - | $16.72 M(-31.6%) |
| Jun 2024 | - | $24.45 M(-25.1%) |
| Mar 2024 | - | $32.65 M(+236.8%) |
| Dec 2023 | $9.69 M(-18.1%) | $9.69 M(-1.7%) |
| Sep 2023 | - | $9.86 M(+12.6%) |
| Jun 2023 | - | $8.75 M(-20.5%) |
| Mar 2023 | - | $11.01 M(-6.9%) |
| Dec 2022 | $11.83 M | $11.83 M(+32.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.91 M(-62.9%) |
| Jun 2022 | - | $24.00 M(-0.5%) |
| Mar 2022 | - | $24.13 M(-0.9%) |
| Dec 2021 | $24.36 M(+74.1%) | $24.36 M(-64.3%) |
| Sep 2021 | - | $68.28 M(+63.6%) |
| Jun 2021 | - | $41.73 M(+71.1%) |
| Mar 2021 | - | $24.39 M(+74.3%) |
| Dec 2020 | $13.99 M(+75.8%) | $13.99 M |
| Dec 2019 | $7.96 M | - |
FAQ
- What is RxSight annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for RxSight?
- What is RxSight annual cash & cash equivalents year-on-year change?
- What is RxSight quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for RxSight?
- What is RxSight quarterly cash and cash equivalents year-on-year change?
What is RxSight annual cash & cash equivalents?
The current annual cash & cash equivalents of RXST is $16.71 M
What is the all time high annual cash & cash equivalents for RxSight?
RxSight all-time high annual cash & cash equivalents is $24.36 M
What is RxSight annual cash & cash equivalents year-on-year change?
Over the past year, RXST annual cash & cash equivalents has changed by +$7.01 M (+72.37%)
What is RxSight quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RXST is $16.71 M
What is the all time high quarterly cash and cash equivalents for RxSight?
RxSight all-time high quarterly cash and cash equivalents is $68.28 M
What is RxSight quarterly cash and cash equivalents year-on-year change?
Over the past year, RXST quarterly cash and cash equivalents has changed by $0.00 (0.00%)